Key result
Novel macrophage AGE receptor displays distinct ligand specificity and inhibition from acetyl-LDL scavenger receptors.
Answers are grounded in this paper and cite their sources.
A high-affinity macrophage receptor has been identified that recognizes proteins modified by a common in vivo process, long-term nonenzymatic reaction of glucose with proteins (AGE proteins). This receptor for glucose-modified proteins is now shown to be distinct from previously described scavenger receptors, using competition and crosscompetition experiments between AGE-modified protein and a variety of in vitro-modified scavenger receptor ligands, including unmodified BSA, unmodified low-density lipoproteins (LDL), acetyl-LDL, maleyl-BSA, and formaldehyde-treated BSA. Furthermore, the specific pattern of AGE-protein receptor inhibition by the polyanionic compounds polyinosinic acid, polyadenylic acid, polyglutamic acid, polycytidylic acid, fucoidin, and heparin was distinctly different from that of acetyl-LDL. By thus selectively recognizing a time-dependent in vivo protein modification, macrophages may preferentially degrade senescent macromolecules, thereby having an important role in the regulation of extracellular protein turnover.
No takes yet. Share an insight, caveat, or question.
Vlassara et al. (1986) studied this question. AGE-modified protein vs. In vitro-modified scavenger receptor ligands (unmodified BSA, unmodified LDL, acetyl-LDL, maleyl-BSA, formaldehyde-treated BSA) was evaluated on Macrophage receptor binding specificity and inhibition pattern. A novel high-affinity macrophage receptor for glucose-modified (AGE) proteins showed distinct ligand competition and polyanionic inhibition patterns compared with acetyl-LDL scavenger receptors.
Synapse has enriched 10 related papers. Consider them for comparative context: